Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

  • Published : Oct-2018
  • Tables : 33
  • Figures : 126
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT2224MR
  • Format : ppt

Key Findings

Top Five Companies Account for 35% Share of the Overall Hormone Replacement Therapy Market

The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players. Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market. Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and Bayer AG collectively – collectively account for 35 percent revenue share of the hormone replacement therapy market from on the global front.

Tier 1 hormone replacement therapy companies are focused on carrying out clinical trials for new product development (NPD). Moreover, these companies are adopting vertical, horizontal and backward integration in a bid to achieve rapid expansion and pace in technological development.

In addition, tier 1 hormone replacement therapy companies are forming alliances to co-develop and commercialize hormone replacement therapy drugs. For instance, Pfizer Inc., and Merck KGaA have formed a strategic alliance to develop avelumab (BAVENCIO) to manage hypothyroidism and other thyroid disorders.

hormone replacement therapy market 0

Agreement between FDA and NASEM to Impact Hormone Replacement Therapy Market Growth

Food and Drug Administration (FDA) has signed an agreement with NASEM (National Academies of Science, Engineering & Medicine) and is carrying out expanded agreements with University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation. Main focus behind this initiative was to conduct research and inform consumers regarding compounded drugs.

NASEM is examining the utility of treating individuals with compounded BHRT (Bioidentical Hormone Replacement Therapy) products. Compounded Bioidentical hormone replacement therapy products such as testosterone and progesterone are used instead of FDA approved hormone replacement therapy drugs as BHRT drugs are considered more safe and natural for patients. This factor is likely to impact the clinical trials of new hormone replacement therapy products in turn challenging the growth of hormone replacement therapy market.

Use of Low Cost Generic Versions of Hormone Replacement Therapy Drugs – An Upcoming Trend

Affordability has always remained a major challenge for any pharmaceutical drug or formulation. Moreover, insufficient healthcare reimbursements have resulted in individuals opting for cheaper drugs with unclear drug effectiveness. This prompted manufactures of hormone replacement therapy drugs to produce generic versions of the formulations in a bid to bridge the gap between purchasing power of people and hormone replacement therapy drug pricing. Companies developing generic hormone replacement therapy drugs are also acquiring FDA approvals, which is direct inference apropos to drug effectiveness. For instance, Teva pharmaceuticals has introduced generic version of Estrace cream and estradiol vaginal cream in 2018. The trend is expected to auger well for the overall growth of the hormone replacement therapy market.

Rising Prevalence of Osteoporosis to Influence Hormone Replacement Therapy Demand

Growing life expectancy is closely associated with degeneration that further translates into osteoporotic fractures. In addition, this condition further results in an increase in gap between spine bones during menopause with diminishing estrogen levels. According to the International Osteoporosis Foundation, osteoporosis causes over 8.9 million fractures annually on the global front and is likely to grow in the coming years. Rising prevalence of osteoporosis among women is expected to trigger the demand for hormone replacement therapy.

Hormone Replacement Therapy Associated with Reduced Dementia – Key Growth Propellant  

Hormone replacement therapy can protect memory which is required to carry out short-term cognitive tasks after menopausal stress. Estrogen-only hormone replacement therapy can facilitate lower stress levels without impacting memory. In addition, hormone replacement therapy also reduces possibilities of both vascular dementia and Alzheimer’s disease.  

Combination Hormone Replacement Therapy Associated with Cancer – Key Growth Deterrent

Use of hormone replacement therapy can lead to cancerous cell development. The use of combination hormone replacement therapy (combination of progesterone and estrogen) can increase the risk of breast cancer by 75 percent even if used for a short timeframe. According to the U.S Women’s Health Initiative, the use of combination hormone replacement therapy comes with the risk of development of several cancers including ovarian and uterus cancers. This aspect is expected to confine the growth in adoption of hormone replacement therapy in the forthcoming years. Other hormone replacement therapy related disorders such as stroke, cardiac disorders and blood clots are further expected to negatively impact the growth of the hormone replacement therapy market.

To know about other key influencing factors, request a free hormone replacement therapy market report sample

Competitive Landscape

The report on hormone replacement therapy market offers intelligence on key participants in the hormone replacement therapy market. The key companies involved in the formulation of hormone replacement therapy products are thoroughly assessed and profiled in the report. Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include Novartis AG, Novo Nordisk A/S, Teva Pharmaceuticals, Mylan N.V and Pfizer Inc.

hormone replacement therapy market 1

Major companies in the hormone replacement therapy market are concentrating on expanding their current product portfolio. New hormone replacement therapy formulations being the core focus, companies are carrying out trials and gain FDA approvals. For instance, Novartis AG’s research and development department delivered 6 critical FDA breakthrough therapy designations and 16 submissions in 2017. In May 2017, Novartis AG announced U.S. FDA’s approval for its hormone replacement therapy tablets for hormone receptor positive and metastatic breast cancer treatment in postmenopausal women.

hormone replacement therapy market 2

In February 2018, Novo Nordisk A/S concluded main phase of REAL 1 – the pivotal phase 3 trial along with somapacitan, a long-acting growth hormone to treat adults with growth hormone deficiency.

Teva Pharmaceuticals Industries Ltd. introduced Vagifem in 2017 for the treatment of atrophic vaginitis. In January 2018, the company launched Estrace cream to treat moderate and severe symptoms of vaginal and vulgar atrophy occurring due to menopause. Likewise, Mylan N.V expanded its US portfolio in the women’s healthcare range with U.S. FDA approval for Estradiol Vaginal Cream to treat vaginal atrophy.

Private equity firms are focused on acquiring emerging participants that are involved in drug delivery systems in the hormone replacement therapy space. For instance, Riverside Company has acquired DoseLogix in a bid to provide innovative dosing dispensers for ensuring accurate dosing medications of hormone replacement therapy and other conditions.

Click to know more on competitive scenario in the hormone replacement therapy market to understand key strategies of market participants

Definition

Hormone replacement therapy, also referred to as menopausal hormone therapy, is used to treat various symptoms related to menopause among women. Hormone replacement therapy replaces hormones that are low in level as women near menopause. There are various types of hormone replacement therapy such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy.

About the Report

The report on hormone replacement therapy market provides incisive insights on all aspects influencing growth in demand for hormone replacement therapy worldwide. The report provides a thorough analysis on demand of hormone replacement therapy across key regions in the globe along with sales of various hormone replacement therapy products.

Key drivers, challenges, trends and opportunities shaping the growth of the hormone replacement therapy market are also covered in the hormone replacement therapy market report. The hormone replacement therapy market report provides historical data assessment on use of hormone replacement therapy, current hormone replacement therapy scenario and future demand of hormone replacement therapy. The forecast projections provided cover a timeline of 10 years (2018-2028).

Market Structure

The hormone replacement therapy market is segmented in detail to cover every angle of the hormone replacement therapy space. The hormone replacement therapy market has been segmented on the basis of product type, by dosage form, by indication, by distribution channel and by region.

Various hormone replacement therapy products such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is covered. By dosage form, hormone replacement therapy market is segmented into tablets, patches, injections, implants and creams. By indications, hormone replacement therapy market is categorized into menopause, osteoporosis, thyroid and growth hormone deficiency. By distribution channel, it is segmented by hospital pharmacies, clinics, retail pharmacies and online pharmacies.

The hormone replacement therapy market is assessed across key regions such as North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Middle East and Africa (MEA) and Japan.

Additional Questions Answered

Apart from key findings mentioned above, the hormone replacement therapy market report also answers additional questions such as:

  • Which is the most attractive regional market for hormone replacement therapy?
  • Which dosage form is largely preferred for using hormone replacement therapy worldwide?
  • Due to which indication is the hormone replacement therapy market is witnessing a significant upswing in demand?
  • Which country in the APEJ region accounts for a higher market share in the APEJ hormone replacement therapy?
  • Which is the most lucrative hormone replacement therapy distribution channel?

Research Methodology

The hormone replacement therapy market is drafted using a unique research methodology comprising of a combination of secondary and primary research methodologies. The data gleaned from primary and secondary research is assessed along with information from external sources. All the statistics are compiled using triangulation method to gain highly accurate projections on hormone replacement therapy market.

Request hormone replacement therapy market report methodology

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. FACT.MR Analysis and Recommendations
     1.4. Wheel of FortuneTM – Opportunity Analysis

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy
     2.3. Scope of Research

3. Market Dynamics
     3.1. Drivers
     3.2. Restraints
     3.3. Opportunity
     3.4. Trends

4. Associate industry Dynamics
     4.1. Key Regulations
     4.2. Political-Economical-Social-Technological-Environment (PESTE) Analysis
     4.3. Average Selling Prices (US$), By each Country

5. Key Inclusion
     5.1. Patient Journey in HRT
     5.2. Physician’s Treatment Preference (Physician Survey’s)
     5.3. Top 5 Prescribed Brands, By each Country

6. Global Hormone replacement therapy Market Analysis and Forecast
     6.1. Global Hormone replacement therapy Market Outlook
            6.1.1. Market Value (US$ Mn) Forecast and Analysis
            6.1.2. Regional Demand Assessment
     6.2. Market Value Share by Region

7. Global Hormone Replacement Therapy Market Analysis and Forecast, By Therapy Type
     7.1. Introduction
            7.1.1. Market Share Analysis By Therapy Type
            7.1.2. Y-o-Y Growth Projections By Therapy type
     7.2. Market Size Analysis By Therapy Type
            7.2.1. Estrogen Replacement Therapy
            7.2.2. Thyroid Hormone Replacement Therapy
            7.2.3. Growth Hormone Replacement Therapy
     7.3. Market Attractiveness Analysis By Therapy Type

8. Global Hormone replacement therapy Market Analysis and Forecast, By Dosage form Type
     8.1. Introduction
            8.1.1. Market Share Analysis By Dosage form Type
            8.1.2. Y-o-Y Growth Projections By Dosage form Type
     8.2. Market Size Analysis By Dosage form Type
            8.2.1. Tablets/ Capsules
            8.2.2. Patches
            8.2.3. Injection
            8.2.4. Implants
            8.2.5. Creams or Gels Market Attractiveness Analysis By Dosage form Type

9. Global Hormone replacement therapy Market Analysis and Forecast, By Disease indications
     9.1. Introduction
            9.1.1. Market Share Analysis By Disease indications
            9.1.2. Y-o-Y Growth Projections By Disease indications
     9.2. Market Size Analysis By Disease indications
            9.2.1. Menopause
            9.2.2. Osteoporosis
            9.2.3. Thyroid
            9.2.4. Growth Hormone Deficiency
     9.3. Market Attractiveness Analysis By Disease Indications

10. Global Hormone replacement therapy Market Analysis and Forecast, By Distribution Channel
     10.1.Introduction
            10.1.1. Market Share Analysis By Distribution Channel
            10.1.2. Y-o-Y Growth Projections By Distribution Channel
     10.2.Market Size Analysis By Distribution Channel
            10.2.1. Hospital Pharmacies
            10.2.2. Retail Pharmacies
            10.2.3. Clinics
            10.2.4. Online Pharmacies

11. North America Hormone Replacement Therapy Market Analysis
     11.1. Introduction
            11.1.1. North America Business Outlook
            11.1.2. North America Hormone Replacement Therapy Market Outlook
     11.2. North America Hormone Replacement Therapy Market Outlook
            11.2.1. Market Value (US$ Mn) Forecast and Analysis
            11.2.2. Country Wise Demand Assessment
                     11.2.2.1. US Market Value Share
                     11.2.2.2. Canada Market Value Share
     11.3. North America Hormone Replacement Therapy Market Analysis by Therapy Type
            11.3.1. Value(US$ Mn) Forecast by Therapy Type
            11.3.2. Y-o-Y Growth Comparison by Therapy Type
     11.4. North America Hormone Replacement Therapy Market Analysis by dosage form Type
            11.4.1. Value(US$ Mn) Forecast by dosage Form Type
            11.4.2. Y-o-Y Growth Comparison by dosage form Type
     11.5. North America Hormone Replacement Therapy Market Analysis by Disease Indication
            11.5.1. Value(US$ Mn) Forecast by Disease Indication
            11.5.2. Y-o-Y Growth Comparison by Disease Indication
     11.6. North America Hormone Replacement Therapy Market Analysis by Distribution Channel
            11.6.1. Value(US$ Mn) Forecast by Distribution Channel
            11.6.2. Y-o-Y Growth Comparison by Distribution Channel
     11.7. Market Attractiveness Analysis
     11.8. List of Key Market Participants By Country
     11.9. Market Trends

12. Latin America Hormone Replacement Therapy Market Analysis
     12.1. Introduction
            12.1.1. Latin America Business Outlook
            12.1.2. Latin America Hormone Replacement Therapy Market Outlook
     12.2. Latin America Hormone Replacement Therapy Market Outlook
            12.2.1. Market Value (US$ Mn) Forecast and Analysis
            12.2.2. Country Wise Demand Assessment
                     12.2.2.1. Brazil
                     12.2.2.2. Mexico
                     12.2.2.3. Rest of LA
     12.3. Latin America Hormone Replacement Therapy Market Analysis by Therapy Type
            12.3.1. Value(US$ Mn) Forecast by Therapy Type
            12.3.2. Y-o-Y Growth Comparison by Therapy Type
     12.4. Latin America Hormone Replacement Therapy Market Analysis by dosage form Type
            12.4.1. Value(US$ Mn) Forecast by dosage Form Type
            12.4.2. Y-o-Y Growth Comparison by dosage form Type
     12.5. Latin America Hormone Replacement Therapy Market Analysis by Disease Indication
            12.5.1. Value(US$ Mn) Forecast by Disease Indication
            12.5.2. Y-o-Y Growth Comparison by Disease Indication
     12.6. Latin America Hormone Replacement Therapy Market Analysis by Distribution Channel
            12.6.1. Value(US$ Mn) Forecast by Distribution Channel
            12.6.2. Y-o-Y Growth Comparison by Distribution Channel
     12.7. Market Attractiveness Analysis
     12.8. List of Key Market Participants By Country
     12.9. Market Trends

13. Europe Hormone Replacement Therapy Market Analysis
     13.1. Introduction
            13.1.1. Europe Business Outlook
            13.1.2. Europe Hormone Replacement Therapy Market Outlook
     13.2. Europe Hormone Replacement Therapy Market Outlook
            13.2.1. Market Value (US$ Mn) Forecast and Analysis
            13.2.2. Country Wise Demand Assessment
                     13.2.2.1. UK
                     13.2.2.2. France
                     13.2.2.3. Germany
                     13.2.2.4. Italy
                     13.2.2.5. Spain
                     13.2.2.6. Russia
                     13.2.2.7. Rest of EU
     13.3. Europe Hormone Replacement Therapy Market Analysis by Therapy Type
            13.3.1. Value(US$ Mn) Forecast by Therapy Type
            13.3.2. Y-o-Y Growth Comparison by Therapy Type
     13.4. Europe Hormone Replacement Therapy Market Analysis by dosage form Type
            13.4.1. Value(US$ Mn) Forecast by dosage Form Type
            13.4.2. Y-o-Y Growth Comparison by dosage form Type
     13.5. Europe Hormone Replacement Therapy Market Analysis by Disease Indication
            13.5.1. Value(US$ Mn) Forecast by Disease Indication
            13.5.2. Y-o-Y Growth Comparison by Disease Indication
     13.6. Europe Hormone Replacement Therapy Market Analysis by Distribution Channel
            13.6.1. Value(US$ Mn) Forecast by Distribution Channel
            13.6.2. Y-o-Y Growth Comparison by Distribution Channel
     13.7. Market Attractiveness Analysis
     13.8. List of Key Market Participants By Country
     13.9. Market Trends

14. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis
     14.1. Introduction
            14.1.1. Asia Pacific ex. Japan Business Outlook
            14.1.2. Asia Pacific ex. Japan Hormone Replacement Therapy Market Outlook
     14.2. Asia Pacific ex. Japan Hormone Replacement Therapy Market Outlook
            14.2.1. Market Value (US$ Mn) Forecast and Analysis
            14.2.2. Country Wise Demand Assessment
                     14.2.2.1. India
                     14.2.2.2. China
                     14.2.2.3. Australia
                     14.2.2.4. Rest of APEJ
     14.3. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Therapy Type
            14.3.1. Value(US$ Mn) Forecast by Therapy Type
            14.3.2. Y-o-Y Growth Comparison by Therapy Type
     14.4. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by dosage form Type
            14.4.1. Value(US$ Mn) Forecast by dosage Form Type
            14.4.2. Y-o-Y Growth Comparison by dosage form Type
     14.5. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Disease Indication
            14.5.1. Value(US$ Mn) Forecast by Disease Indication
            14.5.2. Y-o-Y Growth Comparison by Disease Indication
     14.6. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Distribution Channel
            14.6.1. Value(US$ Mn) Forecast by Distribution Channel
            14.6.2. Y-o-Y Growth Comparison by Distribution Channel
     14.7. Market Attractiveness Analysis
     14.8. List of Key Market Participants By Country
     14.9. Market Trends

15. Japan Hormone Replacement Therapy Market Analysis
     15.1. Introduction
            15.1.1. Japan Business Outlook
            15.1.2. Japan Hormone Replacement Therapy Market Outlook
     15.2. Japan Hormone Replacement Therapy Market Outlook
            15.2.1. Market Value (US$ Mn) Forecast and Analysis
     15.3. Japan Hormone Replacement Therapy Market Analysis by Therapy Type
            15.3.1. Value(US$ Mn) Forecast by Therapy Type
            15.3.2. Y-o-Y Growth Comparison by Therapy Type
     15.4. Japan Hormone Replacement Therapy Market Analysis by dosage form Type
            15.4.1. Value(US$ Mn) Forecast by dosage Form Type
            15.4.2. Y-o-Y Growth Comparison by dosage form Type
     15.5. Japan Hormone Replacement Therapy Market Analysis by Disease Indication
            15.5.1. Value(US$ Mn) Forecast by Disease Indication
            15.5.2. Y-o-Y Growth Comparison by Disease Indication
     15.6. Japan Hormone Replacement Therapy Market Analysis by Distribution Channel
            15.6.1. Value(US$ Mn) Forecast by Distribution Channel
            15.6.2. Y-o-Y Growth Comparison by Distribution Channel
     15.7. Market Attractiveness Analysis
     15.8. List of Key Market Participants By Country
     15.9. Market Trends

16. MEA Hormone Replacement Therapy Market Analysis
     16.1. Introduction
            16.1.1. MEA Business Outlook
            16.1.2. MEA Hormone Replacement Therapy Market Outlook
     16.2. MEA Hormone Replacement Therapy Market Outlook
            16.2.1. Market Value (US$ Mn) Forecast and Analysis
            16.2.2. Country Wise Demand Assessment
                     16.2.2.1. Africa
                     16.2.2.2. GCC Countries
                     16.2.2.3. Rest of MEA
     16.3. MEA Hormone Replacement Therapy Market Analysis by Therapy Type
            16.3.1. Value(US$ Mn) Forecast by Therapy Type
            16.3.2. Y-o-Y Growth Comparison by Therapy Type
     16.4. MEA Hormone Replacement Therapy Market Analysis by dosage form Type
            16.4.1. Value(US$ Mn) Forecast by dosage Form Type
            16.4.2. Y-o-Y Growth Comparison by dosage form Type
     16.5. MEA Hormone Replacement Therapy Market Analysis by Disease Indication
            16.5.1. Value(US$ Mn) Forecast by Disease Indication
            16.5.2. Y-o-Y Growth Comparison by Disease Indication
     16.6. MEA Hormone Replacement Therapy Market Analysis by Distribution Channel
            16.6.1. Value(US$ Mn) Forecast by Distribution Channel
            16.6.2. Y-o-Y Growth Comparison by Distribution Channel
     16.7. Market Attractiveness Analysis
     16.8. List of Key Market Participants By Country
     16.9. Market Trends

17. Competition Landscape
     17.1.Competition Dashboard
     17.2.Industry Structure and Company Market Share
     17.3.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
     17.4.Key Players
            17.4.1. AbbVie, Inc.
            17.4.2. Allergan plc
            17.4.3. Bayer AG
            17.4.4. Eli Lilly and Company
            17.4.5. Endo Pharmaceuticals, Inc.
            17.4.6. F. Hoffmann-La Roche Ltd.
            17.4.7. Merck KGaA
            17.4.8. Mylan N.V.
            17.4.9. Novartis AG
            17.4.10. Novo Nordisk A/S
            17.4.11. Pfizer, Inc.
            17.4.12. Others

18. Assumptions and Acronyms Used

19. Research Methodology
     19.1. Detailed information on the process used to collect information and data for compiling this report

Table 01: Global Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 02: Global Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2013 – 2028
Table 03: Global Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 04: Global Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 05: North America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Country, 2013-2028
Table 06: North America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 07: North America Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 08: North America Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 09: North America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 10: Latin America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Country, 2013-2028
Table 11: Latin America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 12: Latin America Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 13: Latin America Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 14: Latin America Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 15: Europe Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Country, 2013-2028
Table 16: Europe Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 17: Europe Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 18: Europe Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 19: Europe Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 20: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Country, 2013-2028
Table 21: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 22: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 23: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 24: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 25: MEA Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Country, 2013-2028
Table 26: MEA Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 27: MEA Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 28: MEA Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 29: MEA Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028
Table 30: Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2018 – 2028
Table 31: Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Dosage Form, 2018 – 2028
Table 32: Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast By Disease Indication, 2018 – 2028
Table 33: Japan Hormone Replacement Therapy Market Value (US$ Mn) Forecast by Distribution Channel, 2018 – 2028

Figure 01: Global Hormone Replacement Therapy Market Scenario, By Region
Figure 02: Estrogen Replacement Therapy Pricing Analysis, by Conjugated Estrogen Therapy (2017)
Figure 03: Estrogen Replacement Therapy Pricing Analysis, by Conjugated Estrogen Therapy (2017)
Figure 04: Estrogen Replacement Therapy Pricing Analysis, by Estradiol Therapy (2017)
Figure 05: Estrogen Replacement Therapy Pricing Analysis, by Estradiol Therapy (2017)
Figure 06: Distribution of Physicians, By Country
Figure 07: Distribution of Primary Participants By Specialty
Figure 08: Physicians Reported Percentage of Menopause Symptoms
Figure 09: Physicians Prescription Trends for Menopause Symptoms
Figure 10: Global Hormone Replacement Therapy Market Value Share and  BPS Analysis by Therapy Type – 2018 & 2028
Figure 11: Global Hormone Replacement Therapy  Market Y-o-Y Growth Analysis by Therapy Type, 2017 & 2028
Figure 12: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Estrogen Replacement Therapy
Figure 13: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 14: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, Growth Hormone Replacement Therapy
Figure 15: Global Hormone Replacement Therapy Market Attractive Analysis, 2018-2028, By Therapy Type
Figure 16: Global Hormone Replacement Therapy Market Value Share and  BPS Analysis by Dosage Form, 2018 & 2028
Figure 17: Global Hormone Replacement Therapy  Market Y-o-Y Growth Analysis by Dosage Form, 2017 & 2028
Figure 18: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Tablets Dosage Form
Figure 19: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Patches Dosage Form
Figure 20: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Injection Dosage Form
Figure 21: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Implants Dosage Form
Figure 22: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, Creams & Gels Dosage Form
Figure 23: Global Hormone Replacement Therapy Market Attractive Index, 2018-2028, By Dosage Form
Figure 24: Hormone Replacement Therapy Market Value BPS Analysis By Disease Indication– 2017 & 2028
Figure 25: Hormone Replacement Therapy  Market Y-O-Y Growth Analysis By Disease Indication, 2017 & 2028
Figure 26: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Menopause
Figure 27: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Osteoporosis
Figure 28: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Thyroid
Figure 29: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Growth Hormone Deficiency
Figure 30: Global Hormone Replacement Therapy Market Attractive Index, 2018-2028, By Disease Indication
Figure 31: Hormone Replacement Therapy Market Value BPS Analysis by Distribution Channel– 2018 & 2028
Figure 32: Hormone Replacement Therapy  Market Y-O-Y Growth Analysis by Distribution Channel, 2017 & 2028
Figure 33: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Hospital Pharmacy
Figure 34: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Retail Pharmacy
Figure 35: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Clinics
Figure 36: Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028, By Online Pharmacy
Figure 37: Global Hormone Replacement Therapy Market Attractive Index, 2018-2028, by Distribution Channel
Figure 38: North America Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 39: North America Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 40: North America Hormone Replacement Therapy Market Value Share by Country, 2013-2028
Figure 41: North America Hormone Replacement Therapy Market Attractiveness Index, By Country 2018-2028
Figure 42: U.S. Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 43: Canada Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 44: North America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 45: North America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 46: North America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 47: North America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 48: North America Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 49: North America Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 50: North America Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 51: North America Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel
Figure 52: Latin America Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 53: Latin America Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 54: Latin America Hormone Replacement Therapy Market Value Share by Country, 2013-2028
Figure 55: Latin America Hormone Replacement Therapy Market Attractiveness Index, By Country 2018-2028
Figure 56: Brazil Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 57: Mexico Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 58: Rest of LA Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 59: Latin America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 60: Latin America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 61: Latin America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 62: Latin America Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 63: Latin America Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 64: Latin America Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 65: Latin America Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 66: Latin America Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel
Figure 67: Europe Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 68: Europe Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 69: Europe Hormone Replacement Therapy Market Value Share by Country, 2013-2028
Figure 70: Europe Hormone Replacement Therapy Market Attractiveness Index, By Country 2018-2028
Figure 71: UK. Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 72: France Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 73: Germany Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 74: Italy Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 75: Spain Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 76: Russia Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 77: Rest of EU Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 78: Europe Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 79: Europe Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 80: Europe Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 81: Europe Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 82: Europe Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 83: Europe Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 84: Europe Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 85: Europe Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel
Figure 86: Asia Pacific ex. Japan Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 87: Asia Pacific ex. Japan Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 88: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value Share by Country, 2013-2028
Figure 89: Asia Pacific ex. Japan Hormone Replacement Therapy Market Attractiveness Index, By Country 2018-2028
Figure 90: India Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 91: China Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 92: Australia Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 93: Rest of APEJ Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 94: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 95: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 96: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 97: Asia Pacific ex. Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 98: Asia Pacific ex. Japan Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 99: Asia Pacific ex. Japan Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 100: Asia Pacific ex. Japan Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 101: Asia Pacific ex. Japan Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel
Figure 102: MEA Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 103: MEA Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 104: MEA Hormone Replacement Therapy Market Value Share by Country, 2013-2028
Figure 105: MEA Hormone Replacement Therapy Market Attractiveness Index, By Country 2018-2028
Figure 106: Africa Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 107: GCC Countries Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 108: Rest of MEA Hormone Replacement Therapy Market Value & Forecast by Country, 2013-2028
Figure 109: MEA Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 110: MEA Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 111: MEA Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 112: MEA Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 113: MEA Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 114: MEA Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 115: MEA Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 116: MEA Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel
Figure 117: Japan Hormone Replacement Therapy Market Size (US$ Mn) Analysis, 2013–2017,
Figure 118: Japan Hormone Replacement Therapy Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 119: Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Therapy Type
Figure 120: Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Estrogen Hormone Replacement Therapy
Figure 121: Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Thyroid Hormone Replacement Therapy
Figure 122: Japan Hormone Replacement Therapy Market Value (US$ Mn) 2013–2028, By Growth Hormone Replacement Therapy
Figure 123: Japan Hormone Replacement Therapy Market Attractiveness Analysis By Therapy
Figure 124: Japan Hormone Replacement Therapy Market Attractiveness Analysis By Dosage Form
Figure 125: Japan Hormone Replacement Therapy Market Attractiveness Analysis By Indication
Figure 126: Japan Hormone Replacement Therapy Market Attractiveness Analysis By Distribution Channel

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development